FdaApplication
ANDA 062856
Identifiers
- fda_app_no: ANDA062856
Properties
| Property | Value |
|---|---|
| applicant_name | WATSON LABORATORIES INC |
| application_type | ANDA |
| approval_date | 1988-10-26 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 500MG BASE/VIAL | INJECTABLE;INJECTION |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 2GM BASE/VIAL | INJECTABLE;INJECTION |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 4GM BASE/VIAL | INJECTABLE;INJECTION |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 1GM BASE/VIAL | INJECTABLE;INJECTION |
| OXACILLIN SODIUM | OXACILLIN SODIUM | EQ 250MG BASE/VIAL | INJECTABLE;INJECTION |
5 products